TickerFacts.

Dexcom Inc (DXCM): Total Liabilities

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$3.59B
As of 2025-12-31
$3.83B
As of 2026-06-30
+3.3%
3-year compound annual growth
$4.38B2010-12-31: $16.17M2011-12-31: $16.00M2012-12-31: $29.00M2013-12-31: $38.40M2014-12-31: $44.40M2015-12-31: $70.80M2016-12-31: $119.00M2017-12-31: $484.70M2018-12-31: $1.25B2019-12-31: $1.51B2020-12-31: $2.46B2021-12-31: $2.89B2022-12-31: $3.26B2023-12-31: $4.20B2024-12-31: $4.38B2025-12-31: $3.59B$3.59B
2010-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$3.59B-18.0%2026-02-12, Balance as of period end
2024-12-31$4.38B+4.4%2026-02-12, Balance as of period end
2023-12-31$4.20B+28.7%2025-02-18, Balance as of period end
2022-12-31$3.26B+12.8%2024-02-08, Balance as of period end
2021-12-31$2.89Bn/c2023-02-09, Balance as of period end
2020-12-31$2.46B+62.9%2022-02-14, Balance as of period end
2019-12-31$1.51B+20.7%2021-02-11, Balance as of period end
2018-12-31$1.25B+158.4%2020-02-13, Balance as of period end
2017-12-31$484.70M+307.3%2019-02-21, Balance as of period end
2016-12-31$119.00M+68.1%2018-02-27, Balance as of period end
2015-12-31$70.80M+59.5%2017-02-28, Balance as of period end
2014-12-31$44.40M+15.6%2016-02-23, Balance as of period end
2013-12-31$38.40M+32.4%2015-02-25, Balance as of period end
2012-12-31$29.00M+81.3%2014-02-20, Balance as of period end
2011-12-31$16.00M-1.1%2013-02-21, Balance as of period end
2010-12-31$16.17Mn/a2012-02-23, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Dexcom Inc (DXCM)2025-12-31$3.59B-18.0%
ResMed Inc (RMD)2026-06-30$2.38B+7.9%
MiniMed Group, Inc. (MMED)2026-04-24$1.02B+17.0%
West Pharmaceutical Services Inc (WST)2025-12-31$1.09B+13.8%
Globus Medical Inc (GMED)2025-12-31$729.51M-32.1%
Insulet Corp (PODD)2025-12-31$1.68B-10.7%
Solventum Corp (SOLV)2025-12-31$9.24B-19.6%
Teleflex Inc (TFX)2025-12-31$3.82B+35.6%
Baxter International Inc (BAX)2025-12-31$13.95B-25.6%

Compare DXCM, RMD, MMED, WST side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗